Published in Biomaterials on September 01, 1991
Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J (2007) 2.38
In vitro assessments of nanomaterial toxicity. Adv Drug Deliv Rev (2009) 1.67
Engineered polymers for advanced drug delivery. Eur J Pharm Biopharm (2008) 1.17
Stealth properties to improve therapeutic efficacy of drug nanocarriers. J Drug Deliv (2013) 0.99
Enhanced passive pulmonary targeting and retention of PEGylated rigid microparticles in rats. Int J Pharm (2010) 0.94
Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry (1971) 3.38
Persistent disability associated with ankle sprains: a prospective examination of an athletic population. Foot Ankle Int (1998) 2.84
CUT1, an Arabidopsis gene required for cuticular wax biosynthesis and pollen fertility, encodes a very-long-chain fatty acid condensing enzyme. Plant Cell (1999) 2.75
Surgical treatment of drug-resistant epilepsy due to mesial temporal sclerosis. Etiology and significance. Arch Neurol (1968) 2.59
Transit of pharmaceutical dosage forms through the small intestine. Gut (1986) 2.35
Precurrent self-prompting operants in children: "Remembering". J Exp Anal Behav (1981) 2.34
Seed-specific over-expression of an Arabidopsis cDNA encoding a diacylglycerol acyltransferase enhances seed oil content and seed weight. Plant Physiol (2001) 2.31
The Arabidopsis thaliana TAG1 mutant has a mutation in a diacylglycerol acyltransferase gene. Plant J (1999) 2.30
Alteration of seed fatty acid composition by an ethyl methanesulfonate-induced mutation in Arabidopsis thaliana affecting diacylglycerol acyltransferase activity. Plant Physiol (1995) 2.19
PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release (1999) 2.08
Detection of antigen-antibody binding events with the atomic force microscope. Biochemistry (1997) 2.05
Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev (2001) 1.87
The components of sickness: diseases, illnesses, and predicaments. Lancet (1979) 1.72
Comparison of the Single Assessment Numeric Evaluation method and two shoulder rating scales. Outcomes measures after shoulder surgery. Am J Sports Med (1999) 1.71
Central and peripheral thermal control of effectors in homeothermic temperature regulation. Physiol Rev (1986) 1.71
Modification of seed oil content and acyl composition in the brassicaceae by expression of a yeast sn-2 acyltransferase gene. Plant Cell (1997) 1.66
Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res (1994) 1.61
Asymptomatic high-grade internal carotid artery stenosis: is stratification according to risk factors or duplex spectral analysis possible? J Vasc Surg (1989) 1.61
Factors influencing the occurrence of schizophrenia-like psychosis in patients with temporal lobe epilepsy. Psychol Med (1975) 1.58
Duplex ultrasound measurement of postprandial intestinal blood flow: effect of meal composition. Gastroenterology (1988) 1.57
Mental state and temporal lobe epilepsy. A correlative account of 100 patients treated surgically. Epilepsia (1972) 1.56
Epilepsy and the sinister side of schizophrenia. Dev Med Child Neurol (1977) 1.54
Evaluation of impotence in older men. West J Med (1985) 1.54
The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm Res (1993) 1.53
Aspects of seizure disorders. II. On prejudice. Dev Med Child Neurol (1973) 1.51
Clinical, socio-economic, and psychological changes after temporal lobectomy for epilepsy. Br J Psychiatry (1968) 1.51
Electron Microscopy of Staphylococcus aureus Treated with Tetracycline. Science (1962) 1.51
Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. Biochem Biophys Res Commun (1991) 1.50
Histrionicotoxins: roentgen-ray analysis of the novel allenic and acetylenie spiroalkaloids isolated from a Colombian frog, Dendrobates histrionicus. Proc Natl Acad Sci U S A (1971) 1.46
Childhood seizures: a 25-year follow up. Social and medical prognosis. Lancet (1976) 1.42
Heavy metals in some Asian medicines and cosmetics. Public Health (1979) 1.42
Nanoparticles in drug delivery. Crit Rev Ther Drug Carrier Syst (1987) 1.42
In-situ atomic force microscopy study of beta-amyloid fibrillization. J Mol Biol (2000) 1.40
Criteria for the accreditation of noninvasive vascular laboratories. Can J Surg (1994) 1.40
Physicochemical properties of parenteral fat emulsions containing 20% triglyceride; Intralipid and Ivelip. J Clin Pharm Ther (1993) 1.40
Automated conductimetric titrimeter: use in studying ionic solute-solute interactions. J Pharm Sci (1975) 1.39
Driving after temporal lobectomy for epilepsy. Br Med J (1967) 1.39
Prevention of vascular injuries in revision total hip replacement. Can J Surg (1992) 1.38
Arterial complications and total knee arthroplasty. J Am Acad Orthop Surg (2001) 1.38
Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers. Pharm Res (1994) 1.37
Predictors of ovarian reserve in young women with breast cancer. Br J Cancer (2007) 1.35
Interviewing skills of first-year medical students. J Med Educ (1986) 1.34
Surface plasmon resonance analysis of dynamic biological interactions with biomaterials. Biomaterials (2000) 1.33
Biological mechanisms influencing the outcome of seizures in response to fever. Epilepsia (1971) 1.33
The plastidic phosphoglucomutase from Arabidopsis. A reversible enzyme reaction with an important role in metabolic control. Plant Physiol (2000) 1.31
Prospective evaluation of arthroscopic stabilization of acute, initial anterior shoulder dislocations in young athletes. Two- to five-year follow-up. Am J Sports Med (2001) 1.30
Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res (1994) 1.30
Evaluation of the clearance characteristics of bioadhesive systems in humans. Int J Pharm (1999) 1.30
Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254). Osteoarthritis Cartilage (2012) 1.30
A rapid one-step radiometric assay for hepatitis B surface antigen utilizing monoclonal antibodies. J Immunol Methods (1982) 1.26
Characterization of idiopathic premature ovarian failure. Fertil Steril (1996) 1.24
Biodegradable microparticles as controlled release antigen delivery systems. Immunology (1991) 1.24
Predictors of death in nonruptured and ruptured abdominal aortic aneurysms. J Vasc Surg (1996) 1.23
Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection. Crit Rev Ther Drug Carrier Syst (1994) 1.21
Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm Res (1991) 1.20
Chitosan microspheres prepared by spray drying. Int J Pharm (1999) 1.20
Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J Control Release (2001) 1.20
Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen. Immunology (1992) 1.19
Microparticles as potentially orally active immunological adjuvants. Vaccine (1989) 1.19
The effects of femoral graft placement on in vivo knee kinematics after anterior cruciate ligament reconstruction. J Biomech (2011) 1.17
The polyoxyethylene/polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow. FEBS Lett (1992) 1.17
Structural and electronic requirements for potent agonists at a nicotinic receptor. Eur J Pharmacol (1986) 1.16
Secondary hypogonadism in older men: its relation to impotence. J Clin Endocrinol Metab (1990) 1.16
Characterization of the surfaces generated by liposome binding to the modified dextran matrix of a surface plasmon resonance sensor chip. Anal Biochem (2000) 1.15
Incidence and prevalence of copper deficiency following roux-en-y gastric bypass surgery. Int J Obes (Lond) (2011) 1.14
Compliance in medication by Asian immigrants. Nurs Times (1979) 1.13
Synthesis and characterization of potential interferon inducers. Poly(2'-azido-2'-deoxyuridylic acid). Biochemistry (1973) 1.13
Effect of variation in the common "a" determinant on the antigenicity of hepatitis B surface antigen. J Med Virol (2000) 1.13
Lead poisoning and traditional practices: the consequences for world health. A study in Kuwait. Public Health (1981) 1.13
Differential rates of cerebral maturation between sexes and between hemispheres. Evidence from epilepsy. Lancet (1969) 1.13
Transport of nanoparticles across the rat nasal mucosa. J Drug Target (2001) 1.11
Force-induced melting of a short DNA double helix. Eur Biophys J (2001) 1.11
Microencapsulation using emulsification/solvent evaporation: an overview of techniques and applications. Crit Rev Ther Drug Carrier Syst (1990) 1.11
Effect of cytosine, arabinoside, iododeoxyuridine, ethyldeoxyuridine, thiocyanatodeoxyuridine, and ribavirin on tail lesion formation in mice infected with vaccinia virus. Proc Soc Exp Biol Med (1976) 1.10
Morphine kinetics after diamorphine infusion in premature neonates. Br J Clin Pharmacol (1991) 1.09
A potent interferon inducer derived from poly (7-deazainosinic acid). Biochemistry (1974) 1.09
Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake. Pharm Res (1997) 1.08
Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim Biophys Acta (1993) 1.08
Polylactide-poly(ethylene glycol) micellar-like particles as potential drug carriers: production, colloidal properties and biological performance. J Drug Target (2001) 1.07
Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method. J Drug Target (1993) 1.07
Interactions of 3T3 fibroblasts and endothelial cells with defined pore features. J Biomed Mater Res (2002) 1.06
Epi-fluorescence microscopy and image analysis used to measure diffusion coefficients in gel systems. J Pharm Pharmacol (1992) 1.06
Controlled release microparticles for vaccine development. Vaccine (1991) 1.06
Defining the drug incorporation properties of PLA-PEG nanoparticles. Int J Pharm (2000) 1.06
Facial thermal input to the trigeminal spinal nucleus of rabbits and rats. J Comp Neurol (1979) 1.05
Synthesis and characterisation of a degradable poly(lactic acid)-poly(ethylene glycol) copolymer with biotinylated end groups. Biomacromolecules (2001) 1.05
Hysteria. Arch Dis Child (1985) 1.04
Hysteria, play-acting and courage. Br J Psychiatry (1986) 1.04
The role of gamma-scintigraphy in oral drug delivery. Adv Drug Deliv Rev (2001) 1.04
Identification of a dominant immunogenic epitope of the nucleocapsid (HBc) of the hepatitis B virus. J Med Virol (1986) 1.04
An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen. Biochim Biophys Acta (1993) 1.04
The role of arteriography in assessing vascular injuries associated with dislocations of the knee. J Trauma (1993) 1.03
An analysis of a thermal afferent pathway in the rat. J Physiol (1982) 1.03